CFS Investment Advisory Services LLC raised its stake in shares of Colgate-Palmolive (NYSE:CL – Free Report) by 10.1% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 13,114 shares of the company’s stock after purchasing an additional 1,203 shares during the period. CFS Investment Advisory Services LLC’s holdings in Colgate-Palmolive were worth $1,192,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also modified their holdings of the company. Reston Wealth Management LLC acquired a new stake in Colgate-Palmolive in the third quarter valued at approximately $42,000. Capital Performance Advisors LLP acquired a new position in shares of Colgate-Palmolive during the 3rd quarter worth $53,000. Prospera Private Wealth LLC bought a new position in shares of Colgate-Palmolive during the 3rd quarter valued at $64,000. True Wealth Design LLC lifted its stake in shares of Colgate-Palmolive by 1,460.9% in the 3rd quarter. True Wealth Design LLC now owns 718 shares of the company’s stock valued at $75,000 after purchasing an additional 672 shares during the last quarter. Finally, Continuum Advisory LLC boosted its holdings in Colgate-Palmolive by 93.4% in the third quarter. Continuum Advisory LLC now owns 762 shares of the company’s stock worth $79,000 after purchasing an additional 368 shares in the last quarter. 80.41% of the stock is currently owned by hedge funds and other institutional investors.
Insider Transactions at Colgate-Palmolive
In other news, CFO Stanley J. Sutula III sold 45,410 shares of the company’s stock in a transaction that occurred on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total value of $4,273,535.10. Following the sale, the chief financial officer now directly owns 36,726 shares in the company, valued at approximately $3,456,283.86. This represents a 55.29 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. 0.34% of the stock is owned by insiders.
Analysts Set New Price Targets
Colgate-Palmolive Stock Performance
CL opened at $87.88 on Friday. The stock has a market cap of $71.79 billion, a PE ratio of 25.18, a P/E/G ratio of 3.59 and a beta of 0.44. Colgate-Palmolive has a 1 year low of $80.03 and a 1 year high of $109.30. The stock’s 50 day simple moving average is $91.81 and its 200-day simple moving average is $97.44. The company has a current ratio of 1.04, a quick ratio of 0.68 and a debt-to-equity ratio of 9.46.
Colgate-Palmolive Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.28%. The ex-dividend date of this dividend is Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio is 57.31%.
Colgate-Palmolive Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.
Read More
- Five stocks we like better than Colgate-Palmolive
- How to Calculate Options Profits
- Bloom Energy: Powering the Future With Decentralized Energy
- Comparing and Trading High PE Ratio Stocks
- Dividend Powerhouses: Blue-Chip Stocks Built for the Long Haul
- 3 Stocks to Consider Buying in October
- Why Traders Are Buying the Dip on Johnson & Johnson Stock
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL – Free Report).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.